Global Celecoxib Market Growth 2022-2028
As the global economy mends, the 2021 growth of Celecoxib will have significant change from previous year. According to our latest study, the global Celecoxib market size is USD million in 2022 from USD 1243.6 million in 2021, with a change of % between 2021 and 2022. The global Celecoxib market size will reach USD 2232 million in 2028, growing at a CAGR of 8.7% over the analysis period.
The United States Celecoxib market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Celecoxib market, reaching US$ million by the year 2028. As for the Europe Celecoxib landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.
Global main Celecoxib players cover Pfizer Inc, Teva, Mylan, and Apotex, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
This report presents a comprehensive overview, market shares, and growth opportunities of Celecoxib market by product type, application, key manufacturers and key regions and countries.
Segmentation by type: breakdown data from 2017 to 2022, in Section 2.3; and forecast to 2028 in section 12.6
50mg
100mg
200mg
400mg
Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 12.7.
Rheumatoid arthritis
osteoarthritis
Acute pain
Musculoskeletal pain
Other diseases
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the prominent manufacturers in this market, include
Pfizer Inc
Teva
Mylan
Apotex
Lupin
Hengrui Medicine
Frequently Asked Questions
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
- By Type
- By Application
- By Region
- By Country
- By Manufacturer
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Celecoxib Annual Sales 2017-2028
2.1.2 World Current & Future Analysis for Celecoxib by Geographic Region, 2017, 2022 & 2028
2.1.3 World Current & Future Analysis for Celecoxib by Country/Region, 2017, 2022 & 2028
2.2 Celecoxib Segment by Type
2.2.1 50mg
2.2.2 100mg
2.2.3 200mg
2.2.4 400mg
2.3 Celecoxib Sales by Type
2.3.1 Global Celecoxib Sales Market Share by Type (2017-2022)
2.3.2 Global Celecoxib Revenue and Market Share by Type (2017-2022)
2.3.3 Global Celecoxib Sale Price by Type (2017-2022)
2.4 Celecoxib Segment by Application
2.4.1 Rheumatoid arthritis
2.4.2 osteoarthritis
2.4.3 Acute pain
2.4.4 Musculoskeletal pain
2.4.5 Other diseases
2.5 Celecoxib Sales by Application
2.5.1 Global Celecoxib Sale Market Share by Application (2017-2022)
2.5.2 Global Celecoxib Revenue and Market Share by Application (2017-2022)
2.5.3 Global Celecoxib Sale Price by Application (2017-2022)
3 Global Celecoxib by Company
3.1 Global Celecoxib Breakdown Data by Company
3.1.1 Global Celecoxib Annual Sales by Company (2020-2022)
3.1.2 Global Celecoxib Sales Market Share by Company (2020-2022)
3.2 Global Celecoxib Annual Revenue by Company (2020-2022)
3.2.1 Global Celecoxib Revenue by Company (2020-2022)
3.2.2 Global Celecoxib Revenue Market Share by Company (2020-2022)
3.3 Global Celecoxib Sale Price by Company
3.4 Key Manufacturers Celecoxib Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Celecoxib Product Location Distribution
3.4.2 Players Celecoxib Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Celecoxib by Geographic Region
4.1 World Historic Celecoxib Market Size by Geographic Region (2017-2022)
4.1.1 Global Celecoxib Annual Sales by Geographic Region (2017-2022)
4.1.2 Global Celecoxib Annual Revenue by Geographic Region
4.2 World Historic Celecoxib Market Size by Country/Region (2017-2022)
4.2.1 Global Celecoxib Annual Sales by Country/Region (2017-2022)
4.2.2 Global Celecoxib Annual Revenue by Country/Region
4.3 Americas Celecoxib Sales Growth
4.4 APAC Celecoxib Sales Growth
4.5 Europe Celecoxib Sales Growth
4.6 Middle East & Africa Celecoxib Sales Growth
5 Americas
5.1 Americas Celecoxib Sales by Country
5.1.1 Americas Celecoxib Sales by Country (2017-2022)
5.1.2 Americas Celecoxib Revenue by Country (2017-2022)
5.2 Americas Celecoxib Sales by Type
5.3 Americas Celecoxib Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Celecoxib Sales by Region
6.1.1 APAC Celecoxib Sales by Region (2017-2022)
6.1.2 APAC Celecoxib Revenue by Region (2017-2022)
6.2 APAC Celecoxib Sales by Type
6.3 APAC Celecoxib Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Celecoxib by Country
7.1.1 Europe Celecoxib Sales by Country (2017-2022)
7.1.2 Europe Celecoxib Revenue by Country (2017-2022)
7.2 Europe Celecoxib Sales by Type
7.3 Europe Celecoxib Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Celecoxib by Country
8.1.1 Middle East & Africa Celecoxib Sales by Country (2017-2022)
8.1.2 Middle East & Africa Celecoxib Revenue by Country (2017-2022)
8.2 Middle East & Africa Celecoxib Sales by Type
8.3 Middle East & Africa Celecoxib Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Celecoxib
10.3 Manufacturing Process Analysis of Celecoxib
10.4 Industry Chain Structure of Celecoxib
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Celecoxib Distributors
11.3 Celecoxib Customer
12 World Forecast Review for Celecoxib by Geographic Region
12.1 Global Celecoxib Market Size Forecast by Region
12.1.1 Global Celecoxib Forecast by Region (2023-2028)
12.1.2 Global Celecoxib Annual Revenue Forecast by Region (2023-2028)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Celecoxib Forecast by Type
12.7 Global Celecoxib Forecast by Application
13 Key Players Analysis
13.1 Pfizer Inc
13.1.1 Pfizer Inc Company Information
13.1.2 Pfizer Inc Celecoxib Product Offered
13.1.3 Pfizer Inc Celecoxib Sales, Revenue, Price and Gross Margin (2020-2022)
13.1.4 Pfizer Inc Main Business Overview
13.1.5 Pfizer Inc Latest Developments
13.2 Teva
13.2.1 Teva Company Information
13.2.2 Teva Celecoxib Product Offered
13.2.3 Teva Celecoxib Sales, Revenue, Price and Gross Margin (2020-2022)
13.2.4 Teva Main Business Overview
13.2.5 Teva Latest Developments
13.3 Mylan
13.3.1 Mylan Company Information
13.3.2 Mylan Celecoxib Product Offered
13.3.3 Mylan Celecoxib Sales, Revenue, Price and Gross Margin (2020-2022)
13.3.4 Mylan Main Business Overview
13.3.5 Mylan Latest Developments
13.4 Apotex
13.4.1 Apotex Company Information
13.4.2 Apotex Celecoxib Product Offered
13.4.3 Apotex Celecoxib Sales, Revenue, Price and Gross Margin (2020-2022)
13.4.4 Apotex Main Business Overview
13.4.5 Apotex Latest Developments
13.5 Lupin
13.5.1 Lupin Company Information
13.5.2 Lupin Celecoxib Product Offered
13.5.3 Lupin Celecoxib Sales, Revenue, Price and Gross Margin (2020-2022)
13.5.4 Lupin Main Business Overview
13.5.5 Lupin Latest Developments
13.6 Hengrui Medicine
13.6.1 Hengrui Medicine Company Information
13.6.2 Hengrui Medicine Celecoxib Product Offered
13.6.3 Hengrui Medicine Celecoxib Sales, Revenue, Price and Gross Margin (2020-2022)
13.6.4 Hengrui Medicine Main Business Overview
13.6.5 Hengrui Medicine Latest Developments
14 Research Findings and Conclusion
List of Tables
Table 1. Celecoxib Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)
Table 2. Celecoxib Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)
Table 3. Major Players of 50mg
Table 4. Major Players of 100mg
Table 5. Major Players of 200mg
Table 6. Major Players of 400mg
Table 7. Global Celecoxib Sales by Type (2017-2022) & (K Units)
Table 8. Global Celecoxib Sales Market Share by Type (2017-2022)
Table 9. Global Celecoxib Revenue by Type (2017-2022) & ($ million)
Table 10. Global Celecoxib Revenue Market Share by Type (2017-2022)
Table 11. Global Celecoxib Sale Price by Type (2017-2022) & (US$/Unit)
Table 12. Global Celecoxib Sales by Application (2017-2022) & (K Units)
Table 13. Global Celecoxib Sales Market Share by Application (2017-2022)
Table 14. Global Celecoxib Revenue by Application (2017-2022)
Table 15. Global Celecoxib Revenue Market Share by Application (2017-2022)
Table 16. Global Celecoxib Sale Price by Application (2017-2022) & (US$/Unit)
Table 17. Global Celecoxib Sales by Company (2020-2022) & (K Units)
Table 18. Global Celecoxib Sales Market Share by Company (2020-2022)
Table 19. Global Celecoxib Revenue by Company (2020-2022) ($ Millions)
Table 20. Global Celecoxib Revenue Market Share by Company (2020-2022)
Table 21. Global Celecoxib Sale Price by Company (2020-2022) & (US$/Unit)
Table 22. Key Manufacturers Celecoxib Producing Area Distribution and Sales Area
Table 23. Players Celecoxib Products Offered
Table 24. Celecoxib Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 25. New Products and Potential Entrants
Table 26. Mergers & Acquisitions, Expansion
Table 27. Global Celecoxib Sales by Geographic Region (2017-2022) & (K Units)
Table 28. Global Celecoxib Sales Market Share Geographic Region (2017-2022)
Table 29. Global Celecoxib Revenue by Geographic Region (2017-2022) & ($ millions)
Table 30. Global Celecoxib Revenue Market Share by Geographic Region (2017-2022)
Table 31. Global Celecoxib Sales by Country/Region (2017-2022) & (K Units)
Table 32. Global Celecoxib Sales Market Share by Country/Region (2017-2022)
Table 33. Global Celecoxib Revenue by Country/Region (2017-2022) & ($ millions)
Table 34. Global Celecoxib Revenue Market Share by Country/Region (2017-2022)
Table 35. Americas Celecoxib Sales by Country (2017-2022) & (K Units)
Table 36. Americas Celecoxib Sales Market Share by Country (2017-2022)
Table 37. Americas Celecoxib Revenue by Country (2017-2022) & ($ Millions)
Table 38. Americas Celecoxib Revenue Market Share by Country (2017-2022)
Table 39. Americas Celecoxib Sales by Type (2017-2022) & (K Units)
Table 40. Americas Celecoxib Sales Market Share by Type (2017-2022)
Table 41. Americas Celecoxib Sales by Application (2017-2022) & (K Units)
Table 42. Americas Celecoxib Sales Market Share by Application (2017-2022)
Table 43. APAC Celecoxib Sales by Region (2017-2022) & (K Units)
Table 44. APAC Celecoxib Sales Market Share by Region (2017-2022)
Table 45. APAC Celecoxib Revenue by Region (2017-2022) & ($ Millions)
Table 46. APAC Celecoxib Revenue Market Share by Region (2017-2022)
Table 47. APAC Celecoxib Sales by Type (2017-2022) & (K Units)
Table 48. APAC Celecoxib Sales Market Share by Type (2017-2022)
Table 49. APAC Celecoxib Sales by Application (2017-2022) & (K Units)
Table 50. APAC Celecoxib Sales Market Share by Application (2017-2022)
Table 51. Europe Celecoxib Sales by Country (2017-2022) & (K Units)
Table 52. Europe Celecoxib Sales Market Share by Country (2017-2022)
Table 53. Europe Celecoxib Revenue by Country (2017-2022) & ($ Millions)
Table 54. Europe Celecoxib Revenue Market Share by Country (2017-2022)
Table 55. Europe Celecoxib Sales by Type (2017-2022) & (K Units)
Table 56. Europe Celecoxib Sales Market Share by Type (2017-2022)
Table 57. Europe Celecoxib Sales by Application (2017-2022) & (K Units)
Table 58. Europe Celecoxib Sales Market Share by Application (2017-2022)
Table 59. Middle East & Africa Celecoxib Sales by Country (2017-2022) & (K Units)
Table 60. Middle East & Africa Celecoxib Sales Market Share by Country (2017-2022)
Table 61. Middle East & Africa Celecoxib Revenue by Country (2017-2022) & ($ Millions)
Table 62. Middle East & Africa Celecoxib Revenue Market Share by Country (2017-2022)
Table 63. Middle East & Africa Celecoxib Sales by Type (2017-2022) & (K Units)
Table 64. Middle East & Africa Celecoxib Sales Market Share by Type (2017-2022)
Table 65. Middle East & Africa Celecoxib Sales by Application (2017-2022) & (K Units)
Table 66. Middle East & Africa Celecoxib Sales Market Share by Application (2017-2022)
Table 67. Key Market Drivers & Growth Opportunities of Celecoxib
Table 68. Key Market Challenges & Risks of Celecoxib
Table 69. Key Industry Trends of Celecoxib
Table 70. Celecoxib Raw Material
Table 71. Key Suppliers of Raw Materials
Table 72. Celecoxib Distributors List
Table 73. Celecoxib Customer List
Table 74. Global Celecoxib Sales Forecast by Region (2023-2028) & (K Units)
Table 75. Global Celecoxib Sales Market Forecast by Region
Table 76. Global Celecoxib Revenue Forecast by Region (2023-2028) & ($ millions)
Table 77. Global Celecoxib Revenue Market Share Forecast by Region (2023-2028)
Table 78. Americas Celecoxib Sales Forecast by Country (2023-2028) & (K Units)
Table 79. Americas Celecoxib Revenue Forecast by Country (2023-2028) & ($ millions)
Table 80. APAC Celecoxib Sales Forecast by Region (2023-2028) & (K Units)
Table 81. APAC Celecoxib Revenue Forecast by Region (2023-2028) & ($ millions)
Table 82. Europe Celecoxib Sales Forecast by Country (2023-2028) & (K Units)
Table 83. Europe Celecoxib Revenue Forecast by Country (2023-2028) & ($ millions)
Table 84. Middle East & Africa Celecoxib Sales Forecast by Country (2023-2028) & (K Units)
Table 85. Middle East & Africa Celecoxib Revenue Forecast by Country (2023-2028) & ($ millions)
Table 86. Global Celecoxib Sales Forecast by Type (2023-2028) & (K Units)
Table 87. Global Celecoxib Sales Market Share Forecast by Type (2023-2028)
Table 88. Global Celecoxib Revenue Forecast by Type (2023-2028) & ($ Millions)
Table 89. Global Celecoxib Revenue Market Share Forecast by Type (2023-2028)
Table 90. Global Celecoxib Sales Forecast by Application (2023-2028) & (K Units)
Table 91. Global Celecoxib Sales Market Share Forecast by Application (2023-2028)
Table 92. Global Celecoxib Revenue Forecast by Application (2023-2028) & ($ Millions)
Table 93. Global Celecoxib Revenue Market Share Forecast by Application (2023-2028)
Table 94. Pfizer Inc Basic Information, Celecoxib Manufacturing Base, Sales Area and Its Competitors
Table 95. Pfizer Inc Celecoxib Product Offered
Table 96. Pfizer Inc Celecoxib Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 97. Pfizer Inc Main Business
Table 98. Pfizer Inc Latest Developments
Table 99. Teva Basic Information, Celecoxib Manufacturing Base, Sales Area and Its Competitors
Table 100. Teva Celecoxib Product Offered
Table 101. Teva Celecoxib Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 102. Teva Main Business
Table 103. Teva Latest Developments
Table 104. Mylan Basic Information, Celecoxib Manufacturing Base, Sales Area and Its Competitors
Table 105. Mylan Celecoxib Product Offered
Table 106. Mylan Celecoxib Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 107. Mylan Main Business
Table 108. Mylan Latest Developments
Table 109. Apotex Basic Information, Celecoxib Manufacturing Base, Sales Area and Its Competitors
Table 110. Apotex Celecoxib Product Offered
Table 111. Apotex Celecoxib Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 112. Apotex Main Business
Table 113. Apotex Latest Developments
Table 114. Lupin Basic Information, Celecoxib Manufacturing Base, Sales Area and Its Competitors
Table 115. Lupin Celecoxib Product Offered
Table 116. Lupin Celecoxib Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 117. Lupin Main Business
Table 118. Lupin Latest Developments
Table 119. Hengrui Medicine Basic Information, Celecoxib Manufacturing Base, Sales Area and Its Competitors
Table 120. Hengrui Medicine Celecoxib Product Offered
Table 121. Hengrui Medicine Celecoxib Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 122. Hengrui Medicine Main Business
Table 123. Hengrui Medicine Latest Developments
List of Figures
Figure 1. Picture of Celecoxib
Figure 2. Celecoxib Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Celecoxib Sales Growth Rate 2017-2028 (K Units)
Figure 7. Global Celecoxib Revenue Growth Rate 2017-2028 ($ Millions)
Figure 8. Celecoxib Sales by Region (2021 & 2028) & ($ millions)
Figure 9. Product Picture of 50mg
Figure 10. Product Picture of 100mg
Figure 11. Product Picture of 200mg
Figure 12. Product Picture of 400mg
Figure 13. Global Celecoxib Sales Market Share by Type in 2021
Figure 14. Global Celecoxib Revenue Market Share by Type (2017-2022)
Figure 15. Celecoxib Consumed in Rheumatoid arthritis
Figure 16. Global Celecoxib Market: Rheumatoid arthritis (2017-2022) & (K Units)
Figure 17. Celecoxib Consumed in osteoarthritis
Figure 18. Global Celecoxib Market: osteoarthritis (2017-2022) & (K Units)
Figure 19. Celecoxib Consumed in Acute pain
Figure 20. Global Celecoxib Market: Acute pain (2017-2022) & (K Units)
Figure 21. Celecoxib Consumed in Musculoskeletal pain
Figure 22. Global Celecoxib Market: Musculoskeletal pain (2017-2022) & (K Units)
Figure 23. Celecoxib Consumed in Other diseases
Figure 24. Global Celecoxib Market: Other diseases (2017-2022) & (K Units)
Figure 25. Global Celecoxib Sales Market Share by Application (2017-2022)
Figure 26. Global Celecoxib Revenue Market Share by Application in 2021
Figure 27. Celecoxib Revenue Market by Company in 2021 ($ Million)
Figure 28. Global Celecoxib Revenue Market Share by Company in 2021
Figure 29. Global Celecoxib Sales Market Share by Geographic Region (2017-2022)
Figure 30. Global Celecoxib Revenue Market Share by Geographic Region in 2021
Figure 31. Global Celecoxib Sales Market Share by Region (2017-2022)
Figure 32. Global Celecoxib Revenue Market Share by Country/Region in 2021
Figure 33. Americas Celecoxib Sales 2017-2022 (K Units)
Figure 34. Americas Celecoxib Revenue 2017-2022 ($ Millions)
Figure 35. APAC Celecoxib Sales 2017-2022 (K Units)
Figure 36. APAC Celecoxib Revenue 2017-2022 ($ Millions)
Figure 37. Europe Celecoxib Sales 2017-2022 (K Units)
Figure 38. Europe Celecoxib Revenue 2017-2022 ($ Millions)
Figure 39. Middle East & Africa Celecoxib Sales 2017-2022 (K Units)
Figure 40. Middle East & Africa Celecoxib Revenue 2017-2022 ($ Millions)
Figure 41. Americas Celecoxib Sales Market Share by Country in 2021
Figure 42. Americas Celecoxib Revenue Market Share by Country in 2021
Figure 43. United States Celecoxib Revenue Growth 2017-2022 ($ Millions)
Figure 44. Canada Celecoxib Revenue Growth 2017-2022 ($ Millions)
Figure 45. Mexico Celecoxib Revenue Growth 2017-2022 ($ Millions)
Figure 46. Brazil Celecoxib Revenue Growth 2017-2022 ($ Millions)
Figure 47. APAC Celecoxib Sales Market Share by Region in 2021
Figure 48. APAC Celecoxib Revenue Market Share by Regions in 2021
Figure 49. China Celecoxib Revenue Growth 2017-2022 ($ Millions)
Figure 50. Japan Celecoxib Revenue Growth 2017-2022 ($ Millions)
Figure 51. South Korea Celecoxib Revenue Growth 2017-2022 ($ Millions)
Figure 52. Southeast Asia Celecoxib Revenue Growth 2017-2022 ($ Millions)
Figure 53. India Celecoxib Revenue Growth 2017-2022 ($ Millions)
Figure 54. Australia Celecoxib Revenue Growth 2017-2022 ($ Millions)
Figure 55. Europe Celecoxib Sales Market Share by Country in 2021
Figure 56. Europe Celecoxib Revenue Market Share by Country in 2021
Figure 57. Germany Celecoxib Revenue Growth 2017-2022 ($ Millions)
Figure 58. France Celecoxib Revenue Growth 2017-2022 ($ Millions)
Figure 59. UK Celecoxib Revenue Growth 2017-2022 ($ Millions)
Figure 60. Italy Celecoxib Revenue Growth 2017-2022 ($ Millions)
Figure 61. Russia Celecoxib Revenue Growth 2017-2022 ($ Millions)
Figure 62. Middle East & Africa Celecoxib Sales Market Share by Country in 2021
Figure 63. Middle East & Africa Celecoxib Revenue Market Share by Country in 2021
Figure 64. Egypt Celecoxib Revenue Growth 2017-2022 ($ Millions)
Figure 65. South Africa Celecoxib Revenue Growth 2017-2022 ($ Millions)
Figure 66. Israel Celecoxib Revenue Growth 2017-2022 ($ Millions)
Figure 67. Turkey Celecoxib Revenue Growth 2017-2022 ($ Millions)
Figure 68. GCC Country Celecoxib Revenue Growth 2017-2022 ($ Millions)
Figure 69. Manufacturing Cost Structure Analysis of Celecoxib in 2021
Figure 70. Manufacturing Process Analysis of Celecoxib
Figure 71. Industry Chain Structure of Celecoxib
Figure 72. Channels of Distribution
Figure 73. Distributors Profiles
